In Situ Programming of CAR-T Cells: A Pressing Need in Modern Immunotherapy
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In Situ Programming of CAR-T Cells: A Pressing Need in Modern Immunotherapy
Authors
Keywords
-
Journal
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
Volume 71, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-07-08
DOI
10.1007/s00005-023-00683-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Current advances and challenges in CAR T-Cell therapy for solid tumors: tumor-associated antigens and the tumor microenvironment
- (2023) Ting Yan et al. Experimental Hematology & Oncology
- Practical issues in CAR T-cell therapy
- (2023) Ja Min Byun Blood Research
- The hospital exemption pathway for the approval of advanced therapy medicinal products: an underused opportunity? The case of the CAR-T ARI-0001
- (2022) Esteve Trias et al. BONE MARROW TRANSPLANTATION
- Recent advances in lipid nanoparticles for delivery of nucleic acid, mRNA, and gene editing-based therapeutics
- (2022) Hidefumi Mukai et al. Drug Metabolism and Pharmacokinetics
- CAR T cells produced in vivo to treat cardiac injury
- (2022) Joel G. Rurik et al. SCIENCE
- Engineered T Cells: CAR T Cell Therapy and Beyond
- (2022) P. Connor Johnson et al. Current Oncology Reports
- PD-L1 CAR effector cells induce self-amplifying cytotoxic effects against target cells
- (2022) Malgorzata Bajor et al. Journal for ImmunoTherapy of Cancer
- In-Vivo Induced CAR-T Cell for the Potential Breakthrough to Overcome the Barriers of Current CAR-T Cell Therapy
- (2022) Tianqing Xin et al. Frontiers in Oncology
- CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
- (2022) Kevin Pan et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- CAR T-Cell-Based gene therapy for cancers: new perspectives, challenges, and clinical developments
- (2022) Manasi P. Jogalekar et al. Frontiers in Immunology
- Next generations of CAR-T cells - new therapeutic opportunities in hematology?
- (2022) Jaromir Tomasik et al. Frontiers in Immunology
- Automated, scaled, transposon-based production of CAR T cells
- (2022) Dominik Lock et al. Journal for ImmunoTherapy of Cancer
- Co-Stimulatory Receptor Signaling in CAR-T Cells
- (2022) Mackenzie M. Honikel et al. Biomolecules
- Advancements in Cancer Immunotherapies
- (2022) Ruchi Roy et al. Vaccines
- Novel lipid combination for delivery of plasmid DNA to immune cells in the spleen
- (2021) Seigo Kimura et al. JOURNAL OF CONTROLLED RELEASE
- Membrane-destabilizing ionizable phospholipids for organ-selective mRNA delivery and CRISPR–Cas gene editing
- (2021) Shuai Liu et al. NATURE MATERIALS
- Clinical approval of nanotechnology-based SARS-CoV-2 mRNA vaccines: impact on translational nanomedicine
- (2021) Lara Milane et al. Drug Delivery and Translational Research
- CAR-T cell therapy: current limitations and potential strategies
- (2021) Robert C. Sterner et al. Blood Cancer Journal
- Nanocomplex‐Mediated In Vivo Programming to Chimeric Antigen Receptor‐M1 Macrophages for Cancer Therapy
- (2021) Mikyung Kang et al. ADVANCED MATERIALS
- Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs
- (2021) István Tombácz et al. MOLECULAR THERAPY
- Remote controlling of CAR-T cells and toxicity management: Molecular switches and next generation CARs
- (2021) Ehsan Moghanloo et al. Translational Oncology
- AAV-mediated in vivo CAR gene therapy for targeting human T-cell leukemia
- (2021) Waqas Nawaz et al. Blood Cancer Journal
- Bispecific binder redirected lentiviral vector enables in vivo engineering of CAR-T cells
- (2021) Justin T Huckaby et al. Journal for ImmunoTherapy of Cancer
- Chemistry of Lipid Nanoparticles for RNA Delivery
- (2021) Yulia Eygeris et al. ACCOUNTS OF CHEMICAL RESEARCH
- On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles
- (2021) Sean A. Dilliard et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Optimization of phospholipid chemistry for improved lipid nanoparticle (LNP) delivery of messenger RNA (mRNA)
- (2021) Ester Álvarez-Benedicto et al. Biomaterials Science
- Engineered CAR-Macrophages as Adoptive Immunotherapies for Solid Tumors
- (2021) Christopher Sloas et al. Frontiers in Immunology
- Third-Generation CAR T Cells Targeting CD19 Are Associated with an Excellent Safety Profile and Might Improve Persistence of CAR T Cells in Treated Patients
- (2020) Maria-Luisa Schubert et al. BLOOD
- The Effect of Size and Charge of Lipid Nanoparticles Prepared by Microfluidic Mixing on Their Lymph Node Transitivity and Distribution
- (2020) Takashi Nakamura et al. MOLECULAR PHARMACEUTICS
- Engineering Caveolae-Targeted Lipid Nanoparticles To Deliver mRNA to the Lungs
- (2020) Qing Li et al. ACS Chemical Biology
- Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR–Cas gene editing
- (2020) Qiang Cheng et al. Nature Nanotechnology
- Tuning the Antigen Density Requirement for CAR T-cell Activity
- (2020) Robbie G. Majzner et al. Cancer Discovery
- Hinge and Transmembrane Domains of Chimeric Antigen Receptor Regulate Receptor Expression and Signaling Threshold
- (2020) Kento Fujiwara et al. Cells
- CAR-T design: Elements and their synergistic function
- (2020) Jayapriya Jayaraman et al. EBioMedicine
- CD19-Specific CAR-T Cells that Express a PD-1/CD28 Chimeric Switch-Receptor is Effective in Patients with PD-L1 Positive B-Cell Lymphoma
- (2020) Hui Liu et al. CLINICAL CANCER RESEARCH
- A Systematic Study of Unsaturation in Lipid Nanoparticles Leads to Improved mRNA Transfection In Vivo
- (2020) Sang Lee et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- In vitro-transcribed antigen receptor mRNA nanocarriers for transient expression in circulating T cells in vivo
- (2020) N. N. Parayath et al. Nature Communications
- Lymphocytes in Cellular Therapy: Functional Regulation of CAR T Cells
- (2019) Dwivedi Alka et al. Frontiers in Immunology
- Engineering and Design of Chimeric Antigen Receptors
- (2019) Sonia Guedan et al. Molecular Therapy-Methods & Clinical Development
- Construction of a chimeric antigen receptor bearing a nanobody against prostate a specific membrane antigen in prostate cancer
- (2019) Mahmoud Hassani et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Managing the toxicities of CAR T‐cell therapy
- (2019) Sattva S. Neelapu HEMATOLOGICAL ONCOLOGY
- Gene editing for immune cell therapies
- (2019) Stefanie R. Bailey et al. NATURE BIOTECHNOLOGY
- Mannosylation of LNP Results in Improved Potency for Self-Amplifying RNA (SAM) Vaccines
- (2019) Roshan Goswami et al. ACS Infectious Diseases
- Targeting cardiac fibrosis with engineered T cells
- (2019) Haig Aghajanian et al. NATURE
- In vivo generated human CAR T cells eradicate tumor cells
- (2019) Shiwani Agarwal et al. OncoImmunology
- Targeting Negative and Positive Immune Checkpoints with Monoclonal Antibodies in Therapy of Cancer
- (2019) Katsiaryna Marhelava et al. Cancers
- Engineering strategies to overcome the current roadblocks in CAR T cell therapy
- (2019) Sarwish Rafiq et al. Nature Reviews Clinical Oncology
- Optimized DNA electroporation for primary human T cell engineering
- (2018) Zhang Zhang et al. BMC BIOTECHNOLOGY
- Purification of mRNA encoding chimeric antigen receptor is critical for generation of robust T cell response
- (2018) Jessica Bobula Foster et al. HUMAN GENE THERAPY
- Rewiring T-cell responses to soluble factors with chimeric antigen receptors
- (2018) ZeNan L Chang et al. Nature Chemical Biology
- A modular platform for targeted RNAi therapeutics
- (2018) Ranit Kedmi et al. Nature Nanotechnology
- Intrinsic Functional Potential of NK-Cell Subsets Constrains Retargeting Driven by Chimeric Antigen Receptors
- (2018) Vincent Yi Sheng Oei et al. Cancer Immunology Research
- In vivo generation of human CD19‐CAR T cells results in B‐cell depletion and signs of cytokine release syndrome
- (2018) Anett Pfeiffer et al. EMBO Molecular Medicine
- PECAM-1 directed re-targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E-mediated uptake
- (2018) Hamideh Parhiz et al. JOURNAL OF CONTROLLED RELEASE
- Surface-Engineered Lentiviral Vectors for Selective Gene Transfer into Subtypes of Lymphocytes
- (2018) Annika M. Frank et al. Molecular Therapy-Methods & Clinical Development
- Function of Novel Anti-CD19 Chimeric Antigen Receptors with Human Variable Regions Is Affected by Hinge and Transmembrane Domains
- (2017) Leah Alabanza et al. MOLECULAR THERAPY
- In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers
- (2017) Tyrel T. Smith et al. Nature Nanotechnology
- Camelid Single-Domain Antibodies: Historical Perspective and Future Outlook
- (2017) Mehdi Arbabi-Ghahroudi Frontiers in Immunology
- Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells
- (2016) Omkar U. Kawalekar et al. IMMUNITY
- Systemic Gene Silencing in Primary T Lymphocytes Using Targeted Lipid Nanoparticles
- (2015) Srinivas Ramishetti et al. ACS Nano
- Structural Design of Engineered Costimulation Determines Tumor Rejection Kinetics and Persistence of CAR T Cells
- (2015) Zeguo Zhao et al. CANCER CELL
- Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes
- (2015) Norbert Pardi et al. JOURNAL OF CONTROLLED RELEASE
- Exclusive Transduction of Human CD4+T Cells upon Systemic Delivery of CD4-Targeted Lentiviral Vectors
- (2015) Qi Zhou et al. JOURNAL OF IMMUNOLOGY
- Gene Therapy for Wiskott-Aldrich Syndrome--Long-Term Efficacy and Genotoxicity
- (2014) C. J. Braun et al. Science Translational Medicine
- T cells expressing VHH-directed oligoclonal chimeric HER2 antigen receptors: Towards tumor-directed oligoclonal T cell therapy
- (2013) Fatemeh Rahimi Jamnani et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Of CARs and TRUCKs: chimeric antigen receptor (CAR) T cells engineered with an inducible cytokine to modulate the tumor stroma
- (2013) Markus Chmielewski et al. IMMUNOLOGICAL REVIEWS
- Mechanism for the endocytosis of spherical nucleic acid nanoparticle conjugates
- (2013) C. H. J. Choi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nanoparticulate Nonviral Agent for the Effective Delivery of pDNA and siRNA to Differentiated Cells and Primary Human T Lymphocytes
- (2012) Anja Schallon et al. BIOMACROMOLECULES
- T-cell receptor gene transfer exclusively to human CD8+ cells enhances tumor cell killing
- (2012) Q. Zhou et al. BLOOD
- CD28 costimulation improves expansion and persistence of chimeric antigen receptor–modified T cells in lymphoma patients
- (2011) Barbara Savoldo et al. JOURNAL OF CLINICAL INVESTIGATION
- Improving Adoptive T Cell Therapy by Targeting and Controlling IL-12 Expression to the Tumor Environment
- (2011) Ling Zhang et al. MOLECULAR THERAPY
- The Optimal Antigen Response of Chimeric Antigen Receptors Harboring the CD3 Transmembrane Domain Is Dependent upon Incorporation of the Receptor into the Endogenous TCR/CD3 Complex
- (2010) J. S. Bridgeman et al. JOURNAL OF IMMUNOLOGY
- HIV-1 Lentiviral Vector Immunogenicity Is Mediated by Toll-Like Receptor 3 (TLR3) and TLR7
- (2010) K. Breckpot et al. JOURNAL OF VIROLOGY
- Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms
- (2010) Akin Akinc et al. MOLECULAR THERAPY
- Construction and Preclinical Evaluation of an Anti-CD19 Chimeric Antigen Receptor
- (2009) James N. Kochenderfer et al. JOURNAL OF IMMUNOTHERAPY
- Chimeric Receptors Containing CD137 Signal Transduction Domains Mediate Enhanced Survival of T Cells and Increased Antileukemic Efficacy In Vivo
- (2009) Michael C. Milone et al. MOLECULAR THERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search